Organization: Vaxis Therapeutics Inc

US-based Cellegy acquires Vaxis Therapeutics for $6M

San Francisco-based Cellegy Pharmaceuticals Inc has acquired Kingston ON-based Vaxis Therapeutics Inc for $6 million. Vaxis is a spin-off of Queen’s Univ through PARTEQ Innovation, the university’s technology transfer arm. Cellegy will rename the firm Cellegy Canada Inc and the R&D operation will remain in Kingston. Under the agreement, Cellegy will replace Vaxis as the…